Falk College strives to achieve excellence in education not only through good teaching but also through participation in active research. Our students benefit by learning from researchers who are working at the cutting-edge of knowledge, within well-equipped laboratories, and in projects that are both domestic and abroad. We encourage both undergraduates and graduate engagement to achieve not only a rewarding educational experience but also enhanced career opportunities upon graduation. Learn more about the different types of research awards.
Extramural AwardDevelopment and Evaluation of Community-based Approaches and Donor Care Intervention Models for Improving Availability and Safety of Blood for the Management of Severe Anemia in Ghana
This NHLBI-funded study aims to design, implement and evaluate community-based strategies for increasing the blood-donor pool in Ghana. It is one of three consortia funded under the NHLBI’s BLOODSAFE program to improve the availability and safety of blood in Sub-Saharan Africa.
Learn more about this research.
2021-2022 SU CUSE GrantExploring Music Interventions and Mechanisms for Addressing Alcohol Use Disorder
College drinking remains a serious public health concern, with college students more likely to drink frequently, drink heavily, and meet criteria for an alcohol use disorder than their non-college peers. Around 9% of full-time, US college students ages 18 to 22 suffer from alcohol use disorder (AUD), which is defined as an impaired ability to stop or limit alcohol use despite adverse consequences. Risky college drinking is associated with substantial negative consequences, including academic and cognitive impairment, assault, injury, and death. Thus, interventions are needed to address risky college drinking.
Learn more about this research.
2021-2022 Falk Tenure-Track Assistant Professor Seed Grant AwardNarrative Intervention to Reduce Caregiver Stress and Aid Schizophrenia Medication Adherence via WhatsApp (NIRC-SASMAW)
Schizophrenia, a severe form of mental illness, is a global health challenge, with about 1.3 million patients in Sub-Saharan Africa having this disease. Adhering to medications for controlling schizophrenia is a challenge. Patients and caregivers suffer schizophrenia-induced psychological burden (stress and anxiety), which negatively impacts adherence. Thus, efforts to improve adherence among patients would need to tackle the psychological well-being of patients and their caregivers.
Learn more about this research.